Literature DB >> 8973832

Effect of phosphatidylserine on the binding properties of glutamate receptors in brain sections from adult and neonatal rats.

J Gagné1, C Giguère, G Tocco, M Ohayon, R F Thompson, M Baudry, G Massicotte.   

Abstract

The effects of phosphatidylserine (PS) on the binding properties of the AMPA (alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid) and NMDA (N-methyl-D-aspartate) subtypes of glutamate receptors were analyzed by quantitative autoradiography of [3H]AMPA, [3H]6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and [3H]glutamate binding on rat brain tissue sections. Preincubation of brain sections with PS produced an increase in [3H]AMPA binding without modifying the binding properties of [3H]CNQX, an antagonist of AMPA receptors. This effect of PS appeared to be specific for the AMPA subtype of glutamate receptors as the same treatment did not modify [3H]glutamate binding to the NMDA receptors. Furthermore, the PS-induced increase in [3H]AMPA binding was different in various brain structures, being larger in the molecular layer of the cerebellum and almost absent in the striatum. Preincubation with calcium also augmented [3H]AMPA binding, and the lack of additivity of the effects of calcium and PS on [3H]AMPA binding strongly suggests that both treatments share a common mechanism(s) for producing increased agonist binding. Finally, the effect of PS on AMPA receptor properties was markedly reduced in rat brain sections prepared from neonatal rats at a developmental stage that is normally characterized by the absence of LTP expression in certain brain regions. The present data are consistent with the hypothesis that alteration in the lipid composition of synaptic membranes may be an important mechanism for regulating AMPA receptor properties, which could be involved in producing long-lasting changes in synaptic operation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973832     DOI: 10.1016/s0006-8993(96)00897-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport.

Authors:  Robert K M Choy; John M Kemner; James H Thomas
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

Review 2.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 3.  Surfactant phospholipid metabolism.

Authors:  Marianna Agassandian; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2012-09-29

4.  Presence of phosphatidylserine synthesizing enzymes in triton insoluble floating fractions from cerebrocortical plasma membranes: do phosphatidylserine synthesizing enzymes in plasma membrane microdomains play a role in signal transduction?

Authors:  Sandra Buratta; Giuseppina Ferrara; Rita Mozzi
Journal:  Neurochem Res       Date:  2011-01-13       Impact factor: 3.996

5.  N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells.

Authors:  Guergana Tasseva; Laura Cole; Jean E Vance
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

Review 6.  Metabolism and functions of phosphatidylserine in mammalian brain.

Authors:  Rita Mozzi; Sandra Buratta; Gianfrancesco Goracci
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

7.  Long-Term Potentiation at CA3-CA1 Hippocampal Synapses with Special Emphasis on Aging, Disease, and Stress.

Authors:  Ashok Kumar
Journal:  Front Aging Neurosci       Date:  2011-05-20       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.